FIREFLY NEUROSCIENCE, INC. (AIFF)
$1.08+$0.00 (+0.00%) Today
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
No Form 4 activity for AIFF in the last 90 days.
9 Form 4 filings on record, the earliest from Oct 24, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Decaprio - Officer | Grant or award | Common Stock | 44,872 | $0.00 | - | |
| Gregory Lipschitz - Officer | Grant or award | Common Stock | 65,988 | $0.00 | - | |
| Stella Vnook - Director | Grant or award | Deferred Stock Units | 49,262 | $0.00 | - | |
| Brian M. Posner - Director | Grant or award | Deferred Stock Units | 49,262 | $0.00 | - | |
 Arun Swarup Menawat - Director | Grant or award | Deferred Stock Units | 73,892 | $0.00 | - | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 78,031 | $2.07 | $162K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 33,500 | $2.46 | $82K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 19,222 | $2.40 | $46K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 17,500 | $2.74 | $48K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 40,139 | $2.65 | $106K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 45,036 | $2.55 | $115K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 30,126 | $2.94 | $89K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 74,810 | $2.70 | $202K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 32,136 | $2.65 | $85K | |
| Windsor Private Capital LP | Open-market sale | Common Stock | 29,500 | $2.74 | $81K | |
| David Ian Johnson - Officer | Grant or award | Common Stock, par value $0.0001 per share | 557,885 | $0.00 | - |
FIREFLY NEUROSCIENCE, INC. (AIFF) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-12. The full record for AIFF runs to 9 Form 4 filings, the earliest from 2024-10-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AIFF were filed in the last 90 days.
No insider sales of AIFF were filed in the last 90 days. 10 sales are on record for this company.
This page tracks AIFF Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AIFF to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
